Cancer Res Treat.  2021 Jan;53(1):243-251. 10.4143/crt.2020.063.

Impact of the Learning Curve on the Survival of Abdominal or Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer

Affiliations
  • 1Department of Obstetrics and Gynecology, Institute of Women’s Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
  • 2Department of Obstetrics and Gynecology, Yanbian University Hospital, Yanji, China

Abstract

Purpose
The objective of this study was to define the learning curve required to attain satisfactory oncologic outcomes of cervical cancer patients who were undergoing open or minimally invasive surgery for radical hysterectomy, and to analyze the correlation between the learning curve and tumor size.
Materials and Methods
Cervical cancer patients (stage IA-IIA) who underwent open radical hysterectomy (n=280) or minimal invasive radical hysterectomy (n=282) were retrospectively reviewed. The learning curve was evaluated using cumulative sum of 5-year recurrence rates. Survival outcomes were analyzed based on the operation period (“learning period,” P1 vs. “skilled period,” P2), operation mode, and tumor size.
Results
The 5-year disease-free and overall survival rates between open and minimally invasive groups were 91.8% and 89.0% (p=0.098) and 96.1% and 97.2% (p=0.944), respectively. The number of surgeries for learning period was 30 and 60 in open and minimally invasive group, respectively. P2 had better 5-year disease-free survival than P1 after adjusting for risk factors (hazard ratio, 0.392; 95% confidence interval, 0.210 to 0.734; p=0.003). All patients with tumors < 2 cm had similar 5-year disease-free survival regardless of operation mode or learning curve. Minimally invasive group presented lower survival rates than open group when tumors ≥ 2 cm in P2. Preoperative conization improved disease-free survival in patients with tumors ≥ 2 cm, especially in minimally invasive group.
Conclusion
Minimally invasive radical hysterectomy required more cases than open group to achieve acceptable 5-year disease-free survival. When tumors ≥ 2 cm, the surgeon’s proficiency affected survival outcomes in both groups.

Keyword

Uterine cervical neoplasms; Minimally invasive surgical procedures; Learning curve

Figure

  • Fig. 1 Kaplan-Meier estimates of overall survival (A, D) and disease-free survival (B, C, E, F) for cervical cancer patients treated with open radical hysterectomy (ORH) and minimally invasive surgery-radical hysterectomy (MIS-RH). (A) The 5-year overall survival of open and minimally invasive groups were 96.1% (269/280) and 97.2% (274/282), respectively, p=0.944. (B) The 5-year disease-free survival of open and minimally invasive groups were 91.8% (257/280) and 89.0% (251/282), respectively, p=0.098. (C, D) P1 phase presented significantly worse survival rates than P2 phase in the open group (disease-free survival: 85.4% vs. 94.4%, p=0.011; overall survival: 84.1% vs. 97.5%, p=0.001). However, the minimally invasive group did not show statistically significant difference in survival rates of P1 and P2 phase (disease-free survival: 86.0% vs. 92.7%, p=0.233; overall survival: 94.8% vs. 99.1%, p=0.194). Also, there was no significant difference in survival rates between the two groups either in the P1 phase or P2. (E) In the subgroup of patients with tumors < 2 cm, operation period or mode had little effect on disease-free survival. (F) In the subgroup of patient with ≥ 2 cm, P1 phase presented significantly worse disease-free survival than P2 phase in the open group (74.4% [32/43] vs. 91.1% [112/123], p=0.003). The minimally invasive group showed the same tendency but it was not significant (77.4% [65/84] vs. 86.2% [50/58], p=0.193).

  • Fig. 2 Learning curve analysis with regard to 5-year recurrence number. Cumulative sum for 5-year recurrence number of every 10 cases was plotted. The 5-year recurrence number decreased after 30 cases in open group, and after 60 cases in the minimally invasive group. LRH, laparoscopic radical hysterectomy; MIS-RH, minimally invasive surgery-radical hysterectomy; ORH, open radical hysterectomy; RRH, robotically assisted radical hysterectomy.


Reference

References

1. Lelle RJ, Heidenreich W, Schneider J, Morley GW. 100 years radical abdominal operation of cervix carcinoma: in memory of Wertheim’s predecessors. Zentralbl Gynakol. 1995; 117:169–74.
2. Shafer A, Boggess JF. Robotic-assisted endometrial cancer staging and radical hysterectomy with the da Vinci surgical system. Gynecol Oncol. 2008; 111(2 Suppl):S18–23.
Article
3. Paley PJ, Veljovich DS, Shah CA, Everett EN, Bondurant AE, Drescher CW, et al. Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases. Am J Obstet Gynecol. 2011; 204:551.
Article
4. Brudie LA, Backes FJ, Ahmad S, Zhu X, Finkler NJ, Bigsby GEt, et al. Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery. Gynecol Oncol. 2013; 128:309–15.
Article
5. Steed H, Rosen B, Murphy J, Laframboise S, De Petrillo D, Covens A. A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer. Gynecol Oncol. 2004; 93:588–93.
Article
6. Magrina JF, Kho RM, Weaver AL, Montero RP, Magtibay PM. Robotic radical hysterectomy: comparison with laparoscopy and laparotomy. Gynecol Oncol. 2008; 109:86–91.
Article
7. Chen CH, Chiu LH, Chang CW, Yen YK, Huang YH, Liu WM. Comparing robotic surgery with conventional laparoscopy and laparotomy for cervical cancer management. Int J Gynecol Cancer. 2014; 24:1105–11.
Article
8. Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, et al. Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: a five year experience. Surg Oncol. 2016; 25:66–71.
9. Tinelli R, Malzoni M, Cosentino F, Perone C, Fusco A, Cicinelli E, et al. Robotics versus laparoscopic radical hysterectomy with lymphadenectomy in patients with early cervical cancer: a multicenter study. Ann Surg Oncol. 2011; 18:2622–8.
Article
10. Estape R, Lambrou N, Diaz R, Estape E, Dunkin N, Rivera A. A case matched analysis of robotic radical hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy. Gynecol Oncol. 2009; 113:357–61.
Article
11. Shah CA, Beck T, Liao JB, Giannakopoulos NV, Veljovich D, Paley P. Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer. J Gynecol Oncol. 2017; 28:e82.
Article
12. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018; 379:1895–904.
Article
13. Cao L, Xu H, Chen Y, Pan K, Liang Z. A detailed analysis of the learning curve: Da Vinci robot-assisted radical hysterectomy in cervical cancer. J Minim Invasive Gynecol. 2015; 22(6S):S228–9.
Article
14. Yim GW, Kim SW, Nam EJ, Kim S, Kim YT. Learning curve analysis of robot-assisted radical hysterectomy for cervical cancer: initial experience at a single institution. J Gynecol Oncol. 2013; 24:303–12.
Article
15. Heo YJ, Kim S, Min KJ, Lee S, Hong JH, Lee JK, et al. The comparison of surgical outcomes and learning curves of radical hysterectomy by laparoscopy and robotic system for cervical cancer: an experience of a single surgeon. Obstet Gynecol Sci. 2018; 61:468–76.
Article
16. Hawkins DM, Olwell DH. Cumulative sum charts and charting for quality improvement. New York: Springer;1998.
17. Lin JF, Frey M, Huang JQ. Learning curve analysis of the first 100 robotic-assisted laparoscopic hysterectomies performed by a single surgeon. Int J Gynaecol Obstet. 2014; 124:88–91.
Article
18. Oyama K, Kanno K, Kojima R, Shirane A, Yanai S, Ota Y, et al. Short-term outcomes of robotic-assisted versus conventional laparoscopic radical hysterectomy for early-stage cervical cancer: a single-center study. J Obstet Gynaecol Res. 2019; 45:405–11.
Article
19. Shazly SA, Murad MH, Dowdy SC, Gostout BS, Famuyide AO. Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2015; 138:457–71.
Article
20. Wallin E, Floter Radestad A, Falconer H. Introduction of robot-assisted radical hysterectomy for early stage cervical cancer: impact on complications, costs and oncologic outcome. Acta Obstet Gynecol Scand. 2017; 96:536–42.
Article
21. Wang YZ, Deng L, Xu HC, Zhang Y, Liang ZQ. Laparoscopy versus laparotomy for the management of early stage cervical cancer. BMC Cancer. 2015; 15:928.
Article
22. Cao T, Feng Y, Huang Q, Wan T, Liu J. Prognostic and safety roles in laparoscopic versus abdominal radical hysterectomy in cervical cancer: a meta-analysis. J Laparoendosc Adv Surg Tech A. 2015; 25:990–8.
Article
23. Roh HF, Nam SH, Kim JM. Robot-assisted laparoscopic surgery versus conventional laparoscopic surgery in randomized controlled trials: a systematic review and meta-analysis. PLoS One. 2018; 13:e0191628.
Article
24. Zhou J, Xiong BH, Ma L, Cheng Y, Huang W, Zhao L. Robotic vs laparoscopic radical hysterectomy for cervical cancer: a meta-analysis. Int J Med Robot. 2016; 12:145–54.
Article
25. Chong GO, Lee YH, Lee HJ, Hong DG, Lee YS. Comparison of the long-term oncological outcomes between the initial learning period of robotic and the experienced period of laparoscopic radical hysterectomy for early-stage cervical cancer. Int J Gynecol Cancer. 2018; 28:226–32.
Article
26. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018; 68:7–30.
Article
27. Leetanaporn K, Hanprasertpong J. Impact of obesity on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy with pelvic node dissection. Oncol Res Treat. 2019; 42:553–63.
Article
28. Choi E, Lee YY, Suh M, Lee EY, Mai TTX, Ki M, et al. Socio-economic inequalities in cervical and breast cancer screening among women in Korea, 2005–2015. Yonsei Med J. 2018; 59:1026–33.
Article
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr